The first pill to slow Alzheimer’s could come from an unexpected place

Elie Dolgin • November 17, 2026

A drug for erectile dysfunction stemmed mental decline in a year-long global trial of more than 1,500 people.

Alzheimer’s drug research is littered with failures. But this week, clinicians delivered some unexpectedly positive news, courtesy of a Viagra-like pill that has been repurposed for the brain disease.


Continue reading at The Washington Post.

By Elie Dolgin • November 8, 2026
Early trial hints at a radical new fix for type 2 diabetes.
By Elie Dolgin • November 8, 2026
Scientists are exploring whether the flu vaccine can disrupt tumors.